272 related articles for article (PubMed ID: 28625728)
1. Treatment of persistent ventricular tachycardia: Drugs or ablation?
MacIntyre CJ; Sapp JL
Trends Cardiovasc Med; 2017 Oct; 27(7):506-513. PubMed ID: 28625728
[TBL] [Abstract][Full Text] [Related]
2. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
AbdelWahab A; Sapp J
Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
[TBL] [Abstract][Full Text] [Related]
3. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.
Al-Khatib SM; Daubert JP; Anstrom KJ; Daoud EG; Gonzalez M; Saba S; Jackson KP; Reece T; Gu J; Pokorney SD; Granger CB; Hess PL; Mark DB; Stevenson WG
J Cardiovasc Electrophysiol; 2015 Feb; 26(2):151-7. PubMed ID: 25332150
[TBL] [Abstract][Full Text] [Related]
4. Ventricular Tachycardia Ablation in Patients With Implantable Cardioverter Defibrillators Should No Longer Be a Therapy of Last Resort.
Kanagasundram AN; John RM; Stevenson WG
Circulation; 2018 May; 137(18):1885-1887. PubMed ID: 29712693
[No Abstract] [Full Text] [Related]
5. Management of ventricular tachycardia in heart failure.
Baher A; Valderrabano M
Methodist Debakey Cardiovasc J; 2013; 9(1):20-5. PubMed ID: 23519088
[TBL] [Abstract][Full Text] [Related]
6. Treatment of ventricular arrhythmias: What's New?
Markman TM; Nazarian S
Trends Cardiovasc Med; 2019 Jul; 29(5):249-261. PubMed ID: 30268648
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis of randomized controlled trials.
Santangeli P; Muser D; Maeda S; Filtz A; Zado ES; Frankel DS; Dixit S; Epstein AE; Callans DJ; Marchlinski FE
Heart Rhythm; 2016 Jul; 13(7):1552-9. PubMed ID: 26961297
[TBL] [Abstract][Full Text] [Related]
8. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
[TBL] [Abstract][Full Text] [Related]
9. Safety and mid-term outcome of catheter ablation of ventricular tachycardia in octogenarians.
Frontera A; Panniker S; Breitenstein A; Bruno VD; Connolly GM; Wilson D; Rio T; Dhinoja MB; Hussain W; Schilling RJ; Thomas G; Wong T; Hunter RJ; Sacher F; Jaïs P; Duncan E
Europace; 2017 Aug; 19(8):1369-1377. PubMed ID: 27974359
[TBL] [Abstract][Full Text] [Related]
10. Management of ventricular tachycardia in patients with structural heart disease.
Jacobson JT; Weiner JB
Cardiovasc Ther; 2010 Oct; 28(5):255-63. PubMed ID: 20433682
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.
Miyake CY; Webster G; Czosek RJ; Kantoch MJ; Dubin AM; Avasarala K; Atallah J
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):579-87. PubMed ID: 23667268
[TBL] [Abstract][Full Text] [Related]
12. Long-term benefit of first-line peri-implantable cardioverter-defibrillator implant ventricular tachycardia-substrate ablation in secondary prevention patients.
Acosta J; Cabanelas N; Penela D; Fernández-Armenta J; Andreu D; Borràs R; Korshunov V; Cabrera M; Vasanelli F; Arbelo E; Guasch E; Martínez M; Tolosana JM; Mont L; Berruezo A
Europace; 2017 Jun; 19(6):976-982. PubMed ID: 27353322
[TBL] [Abstract][Full Text] [Related]
13. [Frequent ventricular tachycardias: antiarrhythmic drug treatment or catheter ablation?].
Tanner H; Hindricks G; Kottkamp H
Herz; 2005 Nov; 30(7):613-8. PubMed ID: 16333587
[TBL] [Abstract][Full Text] [Related]
14. Ventricular arrhythmias and sudden cardiac death in adults with congenital heart disease.
Khairy P
Heart; 2016 Nov; 102(21):1703-1709. PubMed ID: 27250216
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic Drugs or Catheter Ablation in the Management of Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Kheiri B; Barbarawi M; Zayed Y; Hicks M; Osman M; Rashdan L; Kyi HH; Bachuwa G; Hassan M; Stecker EC; Nazer B; Bhatt DL
Circ Arrhythm Electrophysiol; 2019 Nov; 12(11):e007600. PubMed ID: 31698933
[TBL] [Abstract][Full Text] [Related]
17. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.
Patel C; Yan GX; Kocovic D; Kowey PR
Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):705-11; discussion 712. PubMed ID: 20009081
[No Abstract] [Full Text] [Related]
18. Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only.
Bunch TJ; Weiss JP; Crandall BG; Day JD; May HT; Bair TL; Osborn JS; Mallender C; Fischer A; Brunner KJ; Mahapatra S
Heart Rhythm; 2014 Apr; 11(4):533-40. PubMed ID: 24333283
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic Support in Ventricular Tachycardia Ablation: An International VT Ablation Center Collaborative Group Study.
Turagam MK; Vuddanda V; Atkins D; Santangeli P; Frankel DS; Tung R; Vaseghi M; Sauer WH; Tzou W; Mathuria N; Nakahara S; Dickfeld TM; Bunch TJ; Weiss P; Di Biase L; Tholakanahalli V; Vakil K; Tedrow UB; Stevenson WG; Della Bella P; Shivkumar K; Marchlinski FE; Callans DJ; Natale A; Reddy M; Lakkireddy D
JACC Clin Electrophysiol; 2017 Dec; 3(13):1534-1543. PubMed ID: 29759835
[TBL] [Abstract][Full Text] [Related]
20. Non-pharmacological management of ventricular tachycardia.
Chinushi M; Aizawa Y
Circ J; 2007; 71 Suppl A():A97-105. PubMed ID: 17587747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
